Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEROPENEM for Dermatomyositis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where MEROPENEM was used for Dermatomyositis.

Most Reported Side Effects for MEROPENEM

Side Effect Reports % Deaths Hosp.
Drug ineffective 2,802 20.2% 1,443 1,551
Off label use 1,572 11.3% 536 815
Condition aggravated 706 5.1% 285 429
Pyrexia 669 4.8% 151 453
Multiple organ dysfunction syndrome 655 4.7% 556 411
Drug reaction with eosinophilia and systemic symptoms 626 4.5% 59 418
Septic shock 613 4.4% 468 411
Drug resistance 539 3.9% 229 266
Acute kidney injury 522 3.8% 152 333
Rash 437 3.2% 55 260
Sepsis 413 3.0% 217 241
Thrombocytopenia 406 2.9% 88 221
Product use in unapproved indication 385 2.8% 131 197
Drug ineffective for unapproved indication 382 2.8% 228 221
Pneumonia 381 2.8% 211 250

Other Indications for MEROPENEM

Product used for unknown indication (1,863) Antibiotic therapy (1,121) Pneumonia (853) Infection (655) Sepsis (609) Evidence based treatment (351) Covid-19 (332) Pseudomonas infection (326) Septic shock (292) Klebsiella infection (277)

Other Drugs Used for Dermatomyositis

RITUXIMAB (993) METHOTREXATE (958) HUMAN IMMUNOGLOBULIN G (913) PREDNISONE (744) PREDNISOLONE (652) METHYLPREDNISOLONE (647) MYCOPHENOLATE MOFETIL (636) TACROLIMUS (626) CYCLOPHOSPHAMIDE (511) HYDROXYCHLOROQUINE (419)

Related Pages

MEROPENEM Full Profile All Dermatomyositis Drugs MEROPENEM Demographics MEROPENEM Timeline